MustGrow Biologics Corp.
MGRO.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.29 | -0.24 | 0.44 |
| FCF Yield | -0.88% | -0.78% | -6.44% | -0.97% |
| EV / EBITDA | -13.65 | -43.58 | -35.53 | -45.80 |
| Quality | ||||
| ROIC | -69.34% | -32.17% | -38.11% | -42.65% |
| Gross Margin | 21.19% | 20.87% | 14.31% | 21.30% |
| Cash Conversion Ratio | 0.13 | 0.30 | 2.16 | 0.47 |
| Growth | ||||
| Revenue 3-Year CAGR | 369.87% | 1,651.58% | 840.21% | 299.86% |
| Free Cash Flow Growth | 7.01% | 90.51% | -518.95% | 47.60% |
| Safety | ||||
| Net Debt / EBITDA | 1.12 | -1.29 | -0.71 | 2.00 |
| Interest Coverage | -264.16 | -18.53 | -7.99 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.32 | 1.22 | 1.36 | 0.07 |
| Cash Conversion Cycle | -70.29 | -3.41 | 9.98 | -954.65 |